Omeprazole EP Impurity F Chemische Eigenschaften,Einsatz,Produktion Methoden

Chemische Eigenschaften

Dark Red Solid

Verwenden

8(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one(Mixture of Regioisomers) (Omeprazole EP Impurity F+Omeprazole EP Impurity G) is a mixture of regioisomers of Omeprazole Impurity.

Omeprazole EP Impurity F Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Omeprazole EP Impurity F Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Moxin Chemicals	+86-17320513646 +86-17320513646	anna@molcoo.com	China	9998	58
career henan chemical co	+86-0371-86658258	sales@coreychem.com	China	29766	58
Standardpharm Co. Ltd.	86-714-3992388	overseasales1@yongstandards.com	United States	14320	58
BOC Sciences	+1-631-485-4226	inquiry@bocsci.com	United States	19935	58
Hubei Ipure Biology Co., Ltd	+8618062405514	ada@ipurechemical.com	China	10224	58
Finetech Industry Limited	+86-27-8746-5837 +86-18627785180	info@finetechnology-ind.com	China	9539	58
CR Corporation Limited		fred.wen@crcorporation.cn	China	8642	58
Hangzhou Huarong Pharm Co., Ltd.	571-86758373 +8613588754946	sales@huarongpharm.com	CHINA	3147	58
sgtlifesciences pvt ltd	+91-8790379245	dj@sgtlifesciences.com	China	12351	58
Henan Fengda Chemical Co., Ltd	+86-371-86557731 +86-13613820652	info@fdachem.com	China	20111	58

125656-82-8()Verwandte Suche:

---

• OMeprazole IMpurity F
• 9-Methoxy-1,3-diMethyl-12-thioxobenzo[4',5']iMidazo[2',1':2,3]iMidazo[1,5-a]pyridin-2(12H)-one
• Pyrido[1',2':3,4]iMidazo[1,2-a] benziMidazol-2(12H)-one, 8- Methoxy-1,3-diMethyl-12-thioxo-
• 8-Methoxy-1,3-dimethyl-12-thioxo-pyrido[123,4]imidazo[1,2-a]benzimidazol-2-(12H)-one
• OMeprazole IMpurity-F (EP)
• OMeprazole EP IMpurity F
• 8(9)-Methoxy-1,3-dimethyl-12-thioxopyrido[1’,2’:3,4]imidazo[1,2-a]benzimidazol-2-(12H)-one (Mixture of Regioisomers)
• OMeprazole IMpurity (Mixture of RegioisoMers)
• Esomeprazole Impurity RS
• Omeprazole EP Imp F
• (12H)-one
• Omeprazole impurity 6/Omeprazole EP Impurity F/1,3-Dimethyl-8-methoxy-12-thioxopyrido[1′,2′:3,4]imidazo[1,2-a]benzimidazol-2(12H)-one
• Imp. F (EP):8-Methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]-benzimidazol-2(12H)-one
• Omeprazole EP Impurity F： Omeprazole Impurity F
• 8-Methoxy-1,3-dimethyl-12-thioxopyr
• Omeprazole Impurity (Mixture of F and G)
• 8-Methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one DISCONTINUED, OFFER M262560
• Omeprazole EP Impurity F/ Omeprazole Related Compound F
• 8-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one+9-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one
• Esomeprazole Impurities530
• Omeprazole specified impurity F [EP
• 1,3-Dimethyl-8-methoxy-12-thioxopyrido[1′,2′:3,4]imidazo[1,2-a]benzimidazol-2(12H)-one
• 8-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3] imidazo[1,5-a]pyridin-2(12H)-one compound with 9-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3] imidazo[1,5-a]pyridin-2(12H
• Esomeprazole Impurity 17 (Omeprazole EP Impurity F)
• Omeprazole USP Related Compound F
• Esomeprazole Sodium EP Impurity F
• 8-Methoxy-1,3-dimethyl-12-thioxo-pyrido[1',2'
• 9-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one AND 8-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo
• 8-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one
• Omeprazole EP Impurity F&G 8(9)-methoxy-1,3-dimethyl-12-thioxobenzo[4',5']imidazo[2',1':2,3]imidazo[1,5-a]pyridin-2(12H)-one (Mixture of Regioisomers)
• 8-Methoxy-1,3-dimethyl-12-thioxopyrido[1',2':3,4]imidazo[1,2-a]benzimidazol-2(12H)-one
• 2,12-Dihydro-1,3-dimethyl-8-methoxy-12-thioxobenzo [4,5] pyrido [1,2-c] imidazo [1,2-a] imidazol-2-one
• Omeprazole EP Impurity F (Mixture of F and G)
• Esomeprazole Sodium Impurity F
• Omeprazole Related Compound F
• 125656-82-8
• 125656-82-8+125656-83-9
• Intermediates & Fine Chemicals
• Metabolites & Impurities
• Pharmaceuticals
• DCP